SIRT4 significantly inhibits glutamine metabolism by ADP-ribosylating glutamate dehydrogenase, thereby limiting the supply of energy and materials required for rapid proliferation in tumor cells (59, 60). This evidence concerns the gene SIRT4 and neoplasm.